Patent · US Active

Methods for identifying androgen receptor splice variants in subjects having castration resistant prostate cancer

US11866787B2 · kind B2 · utility

0Cited by

29References

19Claims

0Family size

Assignee

THE JOHNS HOPKINS UNIVERSITY · US

Inventors

Jun Luo · Belmont, US
Emmanuel S. Antonarakis · Piney Grove, US
Changxue Lu · Chengdu, CN

Key dates

Filing date	Sep 11, 2020
Grant date	Jan 9, 2024
Priority date	—
Expiry date	May 4, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Methods of the present disclosure provide for detection of mutations and splice variants of the androgen receptor using a non-invasive approach, RNAseq, for examining circulating tumor cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.